Mutational Profile of Metastatic Breast Cancer Tissue in Patients Treated with Exemestane Plus Everolimus

BACKGROUND: Everolimus has been shown to overcome endocrine resistance in hormone receptor positive advanced breast cancer patients. Predictive biomarkers of everolimus efficacy have been investigated in primary breast cancer tissue without finding univocal results. The goal of this study was to inv...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biomed Res Int
Main Authors: Omarini, Claudia, Filieri, Maria Elisabetta, Bettelli, Stefania, Manfredini, Samantha, Kaleci, Shaniko, Caprera, Cecilia, Nasso, Cecilia, Barbolini, Monica, Guaitoli, Giorgia, Moscetti, Luca, Maiorana, Antonino, Conte, Pier Franco, Cascinu, Stefano, Piacentini, Federico
Formato: Artigo
Idioma:Inglês
Publicado em: Hindawi 2018
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6081542/
https://ncbi.nlm.nih.gov/pubmed/30140695
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/3756981
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados